Information for patients
This leaflet can be made available in other formats including large print, CD and Braille and in languages other than English, upon request.
What is a Pulmonary Embolus?
A pulmonary embolus is a blood clot which has become lodged in the veins of your lungs.
What is Thrombolysis?
Thrombolysis is a treatment which involves a clot busting drug being injected to one of your veins to try and dissolve the pulmonary embolus.
Why do I need this treatment?
You have suffered a serious and life threatening pulmonary embolus. This blood clot is causing significant strain on your heart and lungs and is affecting your blood and oxygen supply to the rest of your body.
When the pulmonary embolus is causing such serious effect on your body, the risk of dying or having long-term complications is much higher. Using blood thinners alone is less effective in this situation.
What tests will I have before this treatment?
You will normally have a combination of the following:
Where will I have this treatment?
You will need to be monitored closely while you are having thrombolysis. You will usually be moved to the high dependency unit. This allows the medical tram to insert different monitors into your arteries or veins.
How is the treatment given?
The treatment is normally given as an injection through a vein. You will usually receive a small dose through an injection (known as a ‘loading dose’) followed by an infusion through a drip over 45 minutes to an hour.
After the thrombolysis is given, you will then normally be put on a different drip called ‘heparin’. This will run continuously for 1-2 days.
This treatment helps to keep your blood thin and stop any more blood clots forming.
What are the risks of this treatment?
As in any treatment, there are potential side effects. The risk of side effects is balanced against the risk of harm from your Pulmonary Embolus.
What are the benefits of this treatment?
The potential benefits of this treatment are dissolving the blood clot which will allow:
- Your blood pressure to return to normal and the ‘shock’ to get better.
- Your oxygen level to return to normal.
- The strain on your other organs to be relieved.
The combination of these things will reduce the chance of you dying from this pulmonary embolus and hopefully speed up your recovery.
Over the longer term, this can reduce the risk of scar tissue forming in the veins of your lungs. This can lower the chance of you developing high blood pressure in your lungs which is known as pulmonary hypertension.
Is there anything that would stop me from having this treatment?
Yes, there are some things which would mean we could definitely not give you the treatment. Your team will check carefully to make sure these do not apply to you.
These include:
- Having had a previous stroke caused by bleeding into your brain.
- If you have a cancer affecting your brain or nervous system.
- Having had a stroke caused by a blood clot in the arteries of your brain within the last 6 months.
- Bleeding from your gut within the last 1 month.
- Any major trauma, surgery or head injury within the last 3 weeks.
- Any other condition which makes you more likely to bleed.
There are also come conditions which may make you likely to have serious bleeding with this treatment. Your team would have to think very carefully about whether thrombolysis was right for you in these circumstances.
These include:
- If you have a TIA (also known as ‘Transient Ischaemic Attack’ or ‘mini-stroke’) within the last 6 months.
- If you are pregnant.
- If you are taking blood thinning treatment.
- If you have known peptic or stomach ulcer disease.
- If you have had a biopsy or other procedure to your body, which could potentially bleed.
- If you have an infection in your heart.
- If your blood pressure is very high and is not responding to the treatment.
- If you have severe liver disease.
How will you monitor me during and after the treatment?
You will be monitored closely with a combination of the following:
How will you know if the treatment has worked?
The most important sign that the treatment has worked will be if your blood pressure and pulse return to normal or improve. Other signs will include your oxygen level improving and whether your blood tests show that the strain on your other organs has improved.
What are the alternatives to Thrombolysis?
The possible alternative to Thrombolysis are:
What will you do if this treatment does not work?
If the treatment does not work then the team will consider 3 options, these include:
It is important to understand that there have been no large studies performed to understand what the best treatment is for patients in whom thrombolysis has not been successful.
There is no ‘one size fits all’ answer, the team will carefully consider how your body is coping with the pulmonary embolus and your health before you become unwell to try and come to an agreement on the best option for you.
If the Thrombolysis is successful, will I need any other treatment for my Pulmonary Embolus?
Yes, you will normally be commenced on blood thinning treatment known as anticoagulation. This is usually in the form of tablets although very occasionally may be given as daily injections under the skin.
This is a life threatening illness. The team will normally recommend that you stay on this treatment indefinitely unless you suffer a side effect.
We will give you a more detailed information leaflet on ‘Anticoagulation’ to further explain this.
Will I need to change any of my usual medicines because of this treatment?
If you are taking other medications that potentially thin your bloods then your team may need to change these.
Further Reading
- Stavros V Konstantinides, Guy Meyer, Cecilia Becattini, Hector
Bueno, Geert-Jan Geersing, Veli-Pekka Harjola, Menno V
Huisman, Marc Humbert, Catriona Sian Jennings, David
Jimenez, Nils Kucher, Irene Marthe Lang, Marieke Lankeit,
Roberto Lorusso, Lucia Mazzolai, Nicolas Meneveau,
Fionnuala Ni Ainle, Paolo Pradoni, Piotr Pruszczyk, Marc
Righini, Adam Torbicki, Eric Van Belle, Jose Luis Zamorano,
ESC Scientific Document Group, 2019 ESC Guidelines for the
Diagnosis and Management of Acute Pulmonary Embolism
Developed in Collaboration with the European Respiratory
Society (ERS): The Task Force for the Diagnosis and
Management of Acute Pulmonary Embolism of the European
Society of Cardiology (ESC), European Heart Journal, Volume
41, Issue 4, 21 January 2020, Pages 543-603,
https://doi.org/10.1093/eurheartj/ehz405.
- Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients
with intermediate – risk pulmonary embolism. N Engl J Med;
370(15): 1402-11.April 10 2014
- Kaplovitch E, Shaw JR, Douketis J. Thrombolysis in
Pulmonary Embolism, An evidence-based approach to treating
life threatening Pulmonary Emboli. Crit Care Clin 36 (2020)
465- 480.
Comments, concerns, compliments or complaints
Patient Experience Team (PET)
We are continually trying to improve the services we provide. We want to know what we’re doing well or if there’s anything which we can improve, that’s why the Patient Experience Team (PET) is here to help. Our Patient Experience Team is here to try to resolve your concerns as quickly as possible. The office is based on the ground floor at the University Hospital of North Tees if you wish to discuss concerns in person. If you would like to contact or request a copy of our PET leaflet, please contact:
Telephone: 01642 624719
Freephone: 0800 092 0084
Opening hours: Monday to Friday, 9:30am to 4:00pm
Email: [email protected]
Out of hours
Out of hours if you wish to speak to a senior member of Trust staff, please contact the hospital switchboard who will bleep the appropriate person.
Telephone: 01642 617617
Data protection and use of patient information
The Trust has developed Data Protection policies in accordance with Data Protection Legislation (UK General Data Protection Regulations and Data Protection Act 2018) and the Freedom of Information Act 2000. All of our staff respect these policies and confidentiality is adhered to at all times. If you require further information on how we process your information please see our Privacy Notices.
Telephone: 01642 383551
Email: [email protected]
Privacy NoticesLeaflet feedback
This leaflet has been produced in partnership with patients and carers. All patient leaflets are regularly reviewed, and any suggestions you have as to how it may be improved are extremely valuable. Please write to the Clinical Governance team, North Tees and Hartlepool NHS Foundation Trust, University Hospital of North Tees, TS19 8PE or:
Email: [email protected]
Leaflet reference: PIL1389
Date for Review: November 2025